Frontiers | Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
Frontiers | Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond - ScienceDirect
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron - ScienceDirect
A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection | eLife
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Vaccines | Free Full-Text | Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
Viruses | Free Full-Text | COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Frontiers | A Molecular Analysis of Memory B Cell and Antibody Responses Against Plasmodium falciparum Merozoite Surface Protein 1 in Children and Adults From Uganda
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera - ScienceDirect
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster - eBioMedicine
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults | Nature Aging
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children - Turner - 2020 - Clinical & Experimental Immunology - Wiley Online Library
View of Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID) | Pathogens and Immunity
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
The evolutionary and functional significance of germline immunoglobulin gene variation: Trends in Immunology
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
